Health Care & Life Sciences » Biotechnology | Arrowhead Pharmaceuticals Corp.

Arrowhead Pharmaceuticals Corp. | Income Statement

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
290.30
175.00
382.00
158.30
31,407.70
16,142.30
SG&A Expense
20,398.40
47,470.60
81,985.50
82,452.70
63,713.20
67,379.30
EBIT
21,859.60
48,641.20
83,939.70
85,554.40
36,995.90
55,936.20
Unusual Expense
8,030.10
10,668.70
9,165.10
3,510.60
2,202.90
432.10
Non Operating Income/Expense
1,074.40
23.20
437.10
57.40
-
7.50
Interest Expense
97.90
-
-
-
-
-
Pretax Income
31,703.10
58,720.10
91,938.50
81,720.60
34,377.90
54,448.10
Income Tax
-
5.30
2.40
2.40
2.40
2.40
Consolidated Net Income
31,703.10
58,725.40
91,940.90
81,723.00
34,380.30
54,450.50
Net Income
31,142.90
58,630.20
91,940.90
81,723.00
34,380.30
54,450.50
Net Income After Extraordinaries
31,142.60
58,630.20
91,940.90
81,723.00
34,380.30
54,450.50
Net Income Available to Common
31,143.30
58,630.20
91,940.90
81,723.00
34,380.30
54,450.50
EPS (Basic)
1.30
1.25
1.60
1.34
0.47
0.65
Basic Shares Outstanding
24,002.20
46,933.00
57,358.40
61,050.90
73,898.60
83,638.50
EPS (Diluted)
1.30
1.25
1.60
1.34
0.47
0.65
Diluted Shares Outstanding
24,002.20
46,933.00
57,358.40
61,050.90
73,898.60
83,638.50
EBITDA
20,108.20
47,295.60
81,603.50
82,294.30
32,305.50
51,237
Non-Operating Interest Income
-
645.50
729.20
265.80
415.10
1,048.50
Minority Interest Expense
560.10
95.20
-
-
-
-
Equity in Affiliates (Pretax)
641.10
78.90
-
-
-
-

About Arrowhead Pharmaceuticals

View Profile
Address
225 South Lake Avenue
Pasadena California 91101
United States
Employees -
Website http://www.arrowheadpharma.com
Updated 07/08/2019
Arrowhead Pharmaceuticals, Inc. engages as a biopharmaceutical company developing targeted RNAi therapeutics. Its pipeline includes clinical programs in chronic hepatitis B virus and partner based programs in obesity and oncology. The company was founded by R.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.